| Entry |
|
|---|
| Name |
gamma-Aminobutyric acid (JAN);
Gammalon (TN) |
|---|
| Formula |
C4H9NO2
|
|---|
| Exact mass |
103.0633
|
|---|
| Mol weight |
103.1198
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG01565 GABA-B receptor agonist
DG03199 Antiepileptic agent
DG02037 GABA mimetic antiepileptic
|
|---|
| Remark |
| Therapeutic category: | 2190 |
|
|---|
| Efficacy |
Brain metabolism enhancer, Neurotransmitter |
|---|
| Comment |
Fatty acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG03 Aminobutyric acid
D00058 gamma-Aminobutyric acid (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D00058 gamma-Aminobutyric acid (JAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D00058 gamma-Aminobutyric acid
DG01565 GABA-B receptor agonist
D00058 gamma-Aminobutyric acid
DG03199 Antiepileptic agent
DG02037 GABA mimetic antiepileptic
D00058 gamma-Aminobutyric acid
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D00058 gamma-Aminobutyric acid
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Metabotropic glutamate receptor family
GABA (metabotropic)
GABBR
D00058 gamma-Aminobutyric acid (JAN) <JP>
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00058 gamma-Aminobutyric acid (JAN) <JP>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 7
1 C1b C 21.8376 -18.3787
2 C6a C 23.0478 -17.6770
3 C1b C 20.6274 -17.6770
4 O6a O 24.2580 -18.3850
5 O6a O 23.0478 -16.2803
6 C1b C 19.4108 -18.3787
7 N1a N 18.2006 -17.6770
BOND 6
1 1 2 1
2 1 3 1
3 2 4 1
4 2 5 2
5 3 6 1
6 6 7 1
|
|---|
